This document is an excerpt from the EUR-Lex website
Document 51994PC0083
Proposal for a EUROPEAN PARLIAMENT AND COUNCIL DECISION adopting an action plan 1995-1999 to combat cancer within the framework for action in the field of public health
Proposal for a EUROPEAN PARLIAMENT AND COUNCIL DECISION adopting an action plan 1995-1999 to combat cancer within the framework for action in the field of public health
Proposal for a EUROPEAN PARLIAMENT AND COUNCIL DECISION adopting an action plan 1995-1999 to combat cancer within the framework for action in the field of public health
/* COM/94/83 final - COD 94/0105 */
OJ C 139, 21.5.1994, p. 12–15
(ES, DA, DE, EL, EN, FR, IT, NL, PT)
Proposal for a EUROPEAN PARLIAMENT AND COUNCIL DECISION adopting an action plan 1995-1999 to combat cancer within the framework for action in the field of public health /* COM/94/83FINAL - COD 94/0105 */
Official Journal C 139 , 21/05/1994 P. 0012
Proposal for a European Parliament and Council Decision adopting an action plan 1995 to 1999 to combat cancer within the framework for action in the field of public health (94/C 139/09) (Text with EEA relevance) COM(94) 83 final - 94/0105(COD) (Submitted by the Commission on 26 April 1994) THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular Article 129 thereof, Having regard to the proposal by the Commission, Having regard to the opinion of the Economic and Social Committee, Having regard to the opinion of the Committee of the Regions, Whereas, at its meetings in June 1985 in Milan and in December 1985 in Luxembourg, the European Council underlined the advantages of launching a European programme against cancer; Whereas the Council and the representatives of the Governments of the Member States meeting within the Council adopted a resolution (1) on 7 July 1986 on a first programme of action of the European Communities against cancer and on 17 May 1990 Decision 90/238/Euratom, ECSC, EEC (2) establishing a second action plan in the context of the 'Europe against cancer` programme for the period 1990 to 1994; Whereas the European Parliament, in its resolution of 15 December 1993, askd that activities against cancer be intensified; Whereas in its resolution of 13 December 1993 (3), the Council invited the Commission to submit in due course a draft third action plan, taking into account the Council resolution of 27 May 1993 on future action in the field of public health as well as the objectives and improvements set out in the Annex thereto; Whereas the prevention of cancer is a priority for Community action within the framework for action in the field of public health set out by the Commission while remaining compatible with other measures already undertaken by the Community in this field; Whereas, in accordance with the principle of subsidiarity, action on matters not under the exclusive competence of the Community, such as action on cancer prevention, must be undertaken by the Community only when, by reason of their scale or effects, it may be better carried out at Community level; Whereas cooperation with the competent international organizations and with non-member countries should be strengthened; Whereas cancer is a major disease associated with lifestyle, and the inherent risk factors need to be overcome, especially tobacco consumption, which also has an effect on combating other diseases, in particular cardiovascular diseases; Whereas, by ensuring wider dissemination of knowledge of the causes of cancer and of its prevention, ensuring improved comparability and dissemination of information on these subjects, and developing complementary actions especially in health education, the programme will contribute to the achievement of the Community objectives set out in Article 129; Whereas an important role is played in the implementation of the programme by the Advisory Committee and the National Coordinating Committees; Whereas, from the operational point of view, the investment made during the preceding action plans in terms of both the European pilot networks and of the mobilization of all those involved in combating cancer should be safeguarded and developed; Whereas, however, possible duplication of effort should be avoided by the promotion of exchanges of experience and by the joint development of basic information modules for the public, for health education and for training members of the health professions; Whereas, in order to increase the value and impact of the action plan, a continuous assessment of the measures undertaken should be carried out, with particular regard to their effectiveness and the achievement of objectives both at national and Community level and, where appropriate, to make the necessary adjustments; Whereas this action plan should be of five-year duration in order to allow sufficient time for actions to be implemented to achieve the objectives set, HAVE DECIDED AS FOLLOWS: Article 1 A Community plan of action against cancer is adopted for the period 1 January 1995 to 31 December 1999. Article 2 The Commission shall ensure implementation of the actions set out in the Annex in accordance with Article 5 and in close cooperation with the Member States and with institutions and organization active in the prevention of cancer. Article 3 The budgetary authority shall determine the financial resources available for each financial year. Article 4 The Commission shall ensure that there is consistency and complementarity between the Community actions to be implemented under this action plan and the other relevant Community programmes and initiatives including the biomedical and health research programme under the Community's framework programmes for research. Article 5 In implementing this action plan, the Commission shall be assisted by an advisory committee consisting of representatives of each Member State, and chaired by the representative of the Commission. The representative of the Commission shall submit to the committee a draft of the measures to be taken. The committee shall deliver its opinion on the draft, within a time limit which the chairman may lay down according to the urgency of the matter, if necessary by taking a vote. The opinion shall be recorded in the minutes; in addition each Member State shall have the right to ask to have its opinion recorded in the minutes. The Commission shall take the utmost account of the opinion delivered by the committee. It shall inform the committee of the manner in which its opinion has been taken into account. Article 6 1. In the course of implementing this action plan, cooperation with non-member countries and with international organizations competent in the field of public health, including the World Health Organization and the International Agency for Research on Cancer, shall be encouraged. 2. The EFTA countries and the countries of central and eastern Europe may be associated with the activities described in the Annex under the conditions set out in the agreements concluded with the Community. Article 7 1. The Commission will publish an annual report on the progress of the action plan and on potential Community financing in the various fields of action, taking into account the reports to be drawn up by each of the Member States. It shall be forwarded to the European Parliament, the Council, the Economic and Social Committee and the Committee of the Regions. 2. On the basis of an interim report to be submitted by the Commission before the end of 1997, the European Parliament and the Council will evaluate the actions undertaken. An overall report will be submitted at the end of the action plan. (1) OJ No C 184, 23. 7. 1986, p. 19. (2) OJ No L 137, 30. 5. 1990, p. 31. (3) OJ No C 15, 18. 1. 1994, p. 1. ANNEX MEASURES TO BE IMPLEMENTED IN THE PERIOD 1995 TO 1999 I. CANCER REGISTERS AND EPIDEMIOLOGICAL STUDIES 1. Support for exchanges of information and experience relating to the collection and dissemination of reliable and comparable data for cancer registers (incidence, mortality and survial rate). Development and strengthening of a European network in cooperation with the International Agency for Research on Cancer (IARC). 2. Support for the carrying out of epidemiological studies at European level and for the dissemination of their conclusions with regard to the identification of carcinogens (physical, chemical and biological), the risks arising from exposure to them, methods of prevention and for estimating survival rates and sources of disparities in those rates. On the basis of these conclusions, support for the drawing up and dissemination of recommendations. Cohort studies on cancer, diet and health (EPIC network), support for epidemiological studies based on research into nutrition as a potential preventive factor (identification of protective agents, modification of specific dietary factors) and, where appropriate, preventive chemical agents. II. PREVENTION A. Public information 3. Establishment of an annual 'Europe against cancer` week. 4. Improving the effectiveness of cancer prevention messages, in particular the recommendations of the European code against cancer, by supporting targeted measures (for teachers, general practitioners, etc.) and pilot projects, studies and analyses of health promotion techniques and assessments of action in this field. 5. Supporting pilot action networks for providing information and exchanges with regard to cancer prevention, taking into account the recommendations of the European code against cancer and those of the committees of experts meeting for this purpose in order to contribute to the highlighting and dissemination of best practice. 6. Promoting information and awareness-raising campaigns for specific population groups on health promotion and cancer prevention, particularly in public places and at work. 7. Encouraging projects with a European dimension relating to the prevention of tobacco consumption; assessment of the implementation of recommendations on the use of tobacco in public places, particularly on public transport and in education establishments. Promotion of a policy aimed at protecting the most vulnerable groups from the risk of passive smoking, in particular pregnant women and children. Assessment of the effect of measures taken in the Member States to reduce tobacco consumption, for example by the banning and control of direct or indirect advertising, exclusion of tobacco from the price index and dissemination of knowledge acquired from such assessments. Support and assessment of pilot measures for preventing tobacco consumption as part of the exchange networks between Member States, for example networks of no-smoking towns, no-smoking hospitals and youth clubs in cooperation with health-care workers and teachers. 8. Selection dissemination and evaluation of the impact of the best methods of reducing tobacco consumption in the Member States as part of pilot measures to implement these methods in liaison with health-care workers. Continuing classification of dangerous substances and preparations with the aim of improving packaging and labelling. B. Health education 9. Contributing to the formulation and implementation of integrated health education programmes in different contexts, with cancer prevention given a particularly important role. Definition and implementation of supplementary cancer prevention projects for specific groups in different contexts. Evaluation of health education initiatives with priority being given to making individuals more aware of their responsibility for their own health, preventing tobacco consumption, promoting a healthy diet and making people aware of the risks associated with excessive exposure of the skin to ultraviolet radiation, targeted at young people. 10. Support for exchanges of experience under the integrated health education programmes with the aim of improving initial and continuing training for teachers and project supervisors in the field of cancer prevention, taking account in this context of the experience gained in the framework of programmes such as Erasmus and the supporting actions of the Commission in the education field. 11. Support for the production, dissemination and evaluation of the impact of Community teaching materials relating to cancer prevention, particularly those tested in the pilot networks. 12. Implementation of studies and dissemination of their conclusions, making it possible to improve the level of knowledge on the perceptions of young people with regard to cancer, tobacco, diet and the risks associated with excessive exposure of the skin to ultraviolet radiation. Carry out analyses with the aim of increasing the effectiveness of preventive programmes among children and young people. C. Training for health-care workers 13. Pursuing the implementation of the Commission recommendation of 8 Novemer 1989 concerning the training of health personnel in the matter of cancer, assistance with the introduction and periodic assessment of the impact of the European pilot networks on initial and continuing training in cancer for the medical, nursing and dentistry professions. 14. Support the mobility of the health professions (particularly trainers) in order to improve theoretical and practical knowledge of cancer (primary prevention, mass screening, particularly for cervical and breast cancer, early diagnosis and quality of care) between those centres of excellence in Member States offering training of a high quality, where such mobility is not ensured under existing Community programmes such as Comett II or Force. 15. Support exchanges of experience and the drawing up and dissemination of conference recommendations for a consensus on good medical practice and of recommendations by groups of experts in order to speed up the dissemination and implementation of the results of controlled studies. Preparation of teaching materials of European interest aimed at improving training in cancer for health-care workers, particularly through the use of interactive computer programmes; assessment of the impact of these materials in the pilot networks. In particular, support for the development, implementation and evaluation of prevention modules intended for the health professions and of models to assist in diagnosis and in making decisions with regard to treatment. III. PREVENTION BY MEANS OF EARLY DETECTION AND SYSTEMATIC SCREENING 16. Support the introduction and evaluation of European pilot project networks in the field of mass screening for breast and cervical cancer, on the basis of recommendations established at European level with regard to ensuring the quality of screening, and support for the organization of meetings to examine the feasibility of extending pilot projects to national and regional levels. 17. Support the preparation at European level and dissemination of a common terminology and classification in order to improve the quality of anatomical and cytopathological interpretation, particularly of suspect growths in the breast and uterus, in particular for anatomists and cytopathologists in the European Community. 18. Support European feasibility studies for early mass screening for other cancers (of the ovary, prostate, skin, colon/rectum and mouth), taking particular account of the medical, psychological, social and economic aspects. IV. STUDIES AND MEASURES RELATING TO THE QUALITY OF CARE FOR CANCER PATIENTS 19. Support European studies and dissemination of their conclusions, particularly in the context of European-level meetings and exchanges of experience, in order to gain a better understanding and improve the effectiveness of quality control methods both in diagnosis (radiological and anatomo-cytopathological examination) and in treatment (radiation therapy and chemotherapy), including palliative care, taking into account the psychological and social aspects, with particular regard to the quality of life of patients. Dissemination and evaluation of best practice in quality assurance in the pilot project networks. V. RESEARCH 20. Make a supporting contribution to selection priorities for cancer research to be carried out under the Community's framework programmes for research and specifically the biomedical and health research programme which includes basic and clinical cancer research. Support for the establishment of an inventory of European basic and clinical cancer research measures; help with the transfer to clinical trials of the results of basic research; information exchange networks for clinical trials in progress, and help with the launching of multiple-centre and multinational clinical trials in order to speed up the assessment of new methods of care.